An Open-label Study to Assess Efficacy and Safety of a Healing Ointment When Used on Infants With Mild-to-moderate Diaper Rash
Overview
- Phase
- Phase 4
- Intervention
- "Cetaphil Healing Ointment"
- Conditions
- Diaper Rash
- Sponsor
- Galderma R&D
- Enrollment
- 26
- Locations
- 1
- Primary Endpoint
- Product Efficacy
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The goal of this clinical trial is to assess the efficacy and safety of a Healing Ointment in infants 2-24 months with mild to moderate diaper rash. The main question it aims to answer is:
• does a Healing Ointment improve skin texture and smoothness in infants with mild to moderate diaper dermatitis? Participants will use a Healing Ointment on the diaper area with every diaper change, have the Investigator perform efficacy and tolerability assessments, and complete questionnaires regarding subject satisfaction.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The subjects must meet all the following criteria to be eligible for the study:
- •Infant subjects aged 2 months to 24 months
- •Females and males
- •All Fitzpatrick skin types I-VI
- •All races and ethnicities
- •Subject diagnosed with mild-to-moderate diaper rash
- •Subject with healthy immune systems
- •Willing to be photographed at each visit (optional)
- •Willing to abstain from use of any other topical diaper rash treatments (ointments, moisturizers, emollients, creams, and wipes) other than the assigned test product and skincare products that have been routinely used on the diaper area during the duration of the study
- •Willing to continue using regular brands of face/body cleanser and not to begin use of any new skincare products other than the test product for the duration of the study
Exclusion Criteria
- •The presence of any of the following exclusion criteria excluded a subject from enrollment in the study:
- •Subject diagnosed with severe diaper rash
- •History of allergy or hypersensitivity to any ingredient of the test product
- •Presence of any disease or lesions near or on the area to be treated, e.g.,
- •Inflammation, active, or chronic infection in or near the treatment area
- •Psoriasis, eczema, rosacea, atopic dermatitis, herpes zoster/herpes simplex, and acanthosis
- •Scars or deformities
- •History of coexisting bacterial infections or medical conditions with uncontrolled gastrointestinal diseases and/or bowel movements
- •History of severe elastosis and/or excessive sun exposure that, in the opinion of the Investigator, could have affected the outcome of the study
- •Planning on having surgeries and/or invasive medical procedures during the course of the study
Arms & Interventions
Treatment Group
All subjects have mild to moderate diaper dermatitis and are given "Cetaphil Healing Ointment" to use with every diaper change.
Intervention: "Cetaphil Healing Ointment"
Outcomes
Primary Outcomes
Product Efficacy
Time Frame: Week 1, Week 3
Product efficacy will be measured by Investigator's evaluation of skin's tactile smoothness, visual skin texture, and diaper dermatitis. Skin smoothness (tactile) and skin texture will be measured on a 10-point modified Griffith's scale, where 0 is the best possible condition and 9 is the worst possible condition, and diaper dermatitis will be measured on a 5-point scale, where 0 is the best possible condition and 4 is the worst possible condition. A decrease in scores indicates an improvement.
Secondary Outcomes
- Subject Satisfaction(Day 1, Week 1, Week 3)
- Product Tolerability(Week 1, Week 3)